Not applicable.
The present invention relates to catheters which cooperate with lock-out devices to prevent unauthorized access by intravenous drug abusers.
Abusers of intravenous drugs such as heroin may suffer from medical conditions requiring insertion of catheters. Be it the treatment of infections by regular intravenous injection of antibiotics, or amelioration of kidney malfunctions by regular dialysis, the drug abuser may be provided with an intravenous peripherally inserted central catheter or PICC line or other catheter arrangement. This catheter, while usually inserted in the hospital, can remain in place for weeks or months, and makes it a simple matter to rapidly inject necessary fluids without difficulty in finding a vein. This ease of intravenous access, however, can be a serious hazard for outpatients who are habitual drug abusers, who can take advantage of this catheter to self-administer unprescribed quantities of narcotics or other controlled substances. Providing a drug abuser with an unsupervised catheter for outpatient care can lead to drug overdose and death. To protect these high risk patients, who might otherwise not need full-time nursing care, they must be hospitalized and retained under supervision for as long as the catheter is in place. Hospitalization is vastly more costly than outpatient care, and represents a less than optimal utilization of health care resources.
U.S. Pat. No. 8,858,505, entitled Catheter Injection Port Lock, discloses a tamper-evident lock for securing access to the injection port of a catheter. The lock has two plastic parts which slide together and which define an interior enclosure which receives a catheter line injection port. The housing halves have overlying flanges, through which a fastener extends to secure the device in a closed configuration. The fastener interacts with the flanges in such a way that it cannot be removed without distorting the device and giving evidence of tampering. Should the patient remove the box to defeat its restrictions, the damage to the box provides ready evidence that the patient has tampered with the device. Also disclosed is a zippered sleeve assembly for protecting the catheter line as it extends between the inlet port and the base.
The U.S. Pat. No. 8,858,505 patent sleeve permits the lock to work with a wide variety of catheters. Yet a specially constructed catheter configured for use with an injection port would offer advantages of lower cost and greater ease of use.
A catheter assembly cooperates with a catheter lock enclosure having a bottom part with an entry slot in an end wall. The catheter assembly has a flexible injection line extending from a picc line base and an puncture resistant exterior tube surrounding the injection line and extending from the picc line base. An exterior barrier extends radially outwardly from the puncture resistant exterior tube, and an interior barrier extends radially outwardly from the injection line and is spaced axially along the injection line from the exterior barrier. A gap is defined between the interior barrier and the exterior barrier, which receives the lock enclosure bottom part end wall to restrain the position of the catheter assembly with respect to the lock enclosure, and to restrict access to an interior of the catheter lock enclosure. The exterior tube and the interior and exterior barriers may be formed, by way of examples, of high density polyethelene, or hard urethane, or Ultra-high-molecular-weight polyethylene (UHMW).
It is an object of the present invention to provide a catheter protective sleeve which is provided as part of the catheter itself for convenient interaction with an injection port lock.
Further objects, features and advantages of the invention will be apparent from the following detailed description when taken in conjunction with the accompanying drawings.
Referring more particularly to
As shown in
The catheter assembly 20 has a puncture resistant exterior tube plastic exterior tube 50 which surrounds the injection line 34 and extends at least to an exterior barrier 52 which is puncture resistant and preferably stiff, and may be ring shaped or any shape which overlies and blocks at least most of the entry slot 47 formed in the end wall 46 of the lock housing 43. An interior barrier 58 extends from the injection line 34 or the exterior tube 50, and is closely spaced from the exterior barrier 52. The interior barrier 58 may also be formed of inflexible plastic, such that the interior barrier 58 can not be pulled through the entry slot 47, and may be of a similar shape to the exterior barrier 52. The exterior and interior barriers 52, 58 are spaced from one another along the injection line 34 by approximately the thickness of the housing end wall 46 e.g., the end wall thickness ±0-5%, 5-10%, or 10-20% of the end wall thickness. The exterior tube 50 and the interior and exterior barriers 58, 52 may be formed, by way of example, of high density polyethylene, or hard urethane, or Ultra-high-molecular-weight polyethylene (UHMW). The exterior tube 50 and barriers 58, 52 may be formed as a unitary part and connected to surround the the injection line 34, or the parts may be co-forming with the flexible injection line. Alternatively, the interior barrier 58 may be formed separately from the exterior barrier 52 and attached to the injection line 34. The puncture resistant exterior tube 50 prevents the patient from piercing the injection line with a hypodermic syringe and injecting fluids into the injection line.
As shown in
An alternative embodiment catheter assembly 69 is shown in
Alternatively, as shown in
The catheter assemblies 20 thus are readily used with catheter locks 22 to effectively provide a tamper evident arrangement along the length of the injection line between the lock and the base 32.
The puncture resistance of the exterior tube or layer 50 may be such as to pass the ASTM 2016 F2878-10 Hypodermic Needle Test Puncture Test Standard, Level 5, which is incorporated herein by reference, which are specifically defines puncture resistance of materials to common hypodermic needles in 21-, 25-, 28-gauge. The level 5 test employs a force applies to hypodermic needles of at least 10 or more Newtons driven at a velocity of 500 mm/minute at a 90° angle to the test material to qualify a material as meeting the standard.
It is understood that the invention is not limited to the particular construction and arrangement of parts herein illustrated and described, but embraces all such modified forms thereof as come within the scope of the following claims.
This application claims the benefit of priority of U.S. provisional patent App. No. 62/220,948, filed Sep. 18, 2015, the disclosure of which is incorporated by reference herein.
Number | Date | Country | |
---|---|---|---|
62220948 | Sep 2015 | US | |
62220767 | Sep 2015 | US |